ITT shares have seen their fair value price target increase modestly from $206.36 to $208.91 per share, as analysts grow more optimistic about the company’s outlook. This subtle adjustment comes as a ...

Eflornithine plus Gleostine improved OS and PFS in recurrent grade 3 IDH-mutated astrocytoma compared to Gleostine alone. The STELLAR study reclassified patients using updated WHO 2021 criteria, ...

ITT (ITT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most ...

City Council elects a new chair and vice chair each year. Councilors serve at-large and not by district or party.

-- Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits for patients with recurrent grade 3 astrocytoma who were ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...

ITT is Parker Hannifin’s counterpart in the Industrial Machinery & Supplies & Components industry that offers: 1) A lower valuation (P/OpInc) relative to Parker Hannifin stock 2) However, higher ...

Total Orders: Nearly $1 billion, up 3%. Revenue: $999 million, up 13% total and 6% organic. Operating Income Growth: Nearly twice the organic sales growth rate. Operating Margin Expansion: Over 100 ...

Engineered components manufacturer for critical industries ITT Inc. (NYSE: ITT) reported Q3 CY2025 results exceeding the market’s revenue expectations , with sales up 12.9% year on year to $999.1 ...

ITT Inc.’s ITT second-quarter 2025 adjusted earnings of $1.64 per share surpassed the Zacks Consensus Estimate of $1.62. The bottom line jumped 10.1% year over year, aided by an increase in sales ...

ITT Inc.’s ITT fourth-quarter 2024 adjusted earnings of $1.50 per share surpassed the Zacks Consensus Estimate of $1.47. The bottom line jumped 11.9% year over year, aided by an increase in sales ...